Ascletis Pharma Inc. (1672.HK)

HKD 2.55

(-10.21%)

Total Assets Summary of Ascletis Pharma Inc.

Ascletis Pharma Inc.'s latest annual total assets in 2023 was 2.49 Billion CNY , down -6.25% from previous year.
Ascletis Pharma Inc.'s latest quarterly total assets in 2024 Q2 was 2.27 Billion CNY , down 0.0% from previous quarter.
Ascletis Pharma Inc. reported annual total assets of 2.65 Billion CNY in 2022, down -6.11% from previous year.
Ascletis Pharma Inc. reported annual total assets of 2.82 Billion CNY in 2021, down -7.73% from previous year.
Ascletis Pharma Inc. reported quarterly total assets of 2.27 Billion CNY for 2024 Q1, down -8.63% from previous quarter.
Ascletis Pharma Inc. reported quarterly total assets of 2.65 Billion CNY for 2023 Q1, up 0.1% from previous quarter.

Annual Total Assets Chart of Ascletis Pharma Inc. (2023 - 2016)

Historical Annual Total Assets of Ascletis Pharma Inc. (2023 - 2016)

Year	Total Assets	Total Assets Growth
2023	2.49 Billion CNY	-6.25%
2022	2.65 Billion CNY	-6.11%
2021	2.82 Billion CNY	-7.73%
2020	3.06 Billion CNY	-10.49%
2019	3.42 Billion CNY	-2.87%
2018	3.52 Billion CNY	255.87%
2017	991.25 Million CNY	84.84%
2016	536.26 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	2.27 Billion CNY	0.0%
2024 Q1	2.27 Billion CNY	-8.63%
2023 Q1	2.65 Billion CNY	0.1%
2023 FY	2.49 Billion CNY	-6.25%
2023 Q4	2.49 Billion CNY	0.0%
2023 Q3	2.49 Billion CNY	-6.35%
2023 Q2	2.65 Billion CNY	0.0%
2022 Q3	2.65 Billion CNY	-5.85%
2022 Q2	2.82 Billion CNY	0.0%
2022 Q1	2.82 Billion CNY	-0.28%
2022 Q4	2.65 Billion CNY	0.0%
2022 FY	2.65 Billion CNY	-6.11%
2021 FY	2.82 Billion CNY	-7.73%
2021 Q3	2.82 Billion CNY	-3.71%
2021 Q4	2.82 Billion CNY	0.0%
2021 Q1	2.93 Billion CNY	-4.18%
2021 Q2	2.93 Billion CNY	0.0%
2020 Q2	3.38 Billion CNY	0.0%
2020 Q3	3.06 Billion CNY	-9.49%
2020 Q4	3.06 Billion CNY	0.0%
2020 Q1	3.38 Billion CNY	-1.11%
2020 FY	3.06 Billion CNY	-10.49%
2019 Q1	3.47 Billion CNY	-1.6%
2019 FY	3.42 Billion CNY	-2.87%
2019 Q4	3.42 Billion CNY	0.0%
2019 Q3	3.42 Billion CNY	-1.29%
2019 Q2	3.47 Billion CNY	0.0%
2018 Q1	889.9 Million CNY	-10.22%
2018 FY	3.52 Billion CNY	255.87%
2018 Q4	3.52 Billion CNY	0.0%
2018 Q3	3.52 Billion CNY	274.8%
2018 Q2	941.18 Million CNY	5.76%
2017 FY	991.25 Million CNY	84.84%
2017 Q1	- CNY	0.0%
2017 Q3	991.25 Million CNY	0.0%
2017 Q4	991.25 Million CNY	0.0%
2016 FY	536.26 Million CNY	0.0%

Peer Total Assets Comparison of Ascletis Pharma Inc.

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-507.575%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	77.853%